Citigroup’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-18,878
| Closed | -$211K | – | 5222 |
|
2022
Q4 | $211K | Buy |
18,878
+18,564
| +5,912% | +$207K | ﹤0.01% | 3013 |
|
2022
Q3 | $2K | Sell |
314
-198
| -39% | -$1.26K | ﹤0.01% | 4760 |
|
2022
Q2 | $2K | Sell |
512
-531
| -51% | -$2.07K | ﹤0.01% | 5150 |
|
2022
Q1 | $12K | Sell |
1,043
-87,830
| -99% | -$1.01M | ﹤0.01% | 4681 |
|
2021
Q4 | $1.62M | Buy |
88,873
+87,603
| +6,898% | +$1.6M | ﹤0.01% | 2130 |
|
2021
Q3 | $15K | Buy |
1,270
+740
| +140% | +$8.74K | ﹤0.01% | 4609 |
|
2021
Q2 | $9K | Buy |
530
+128
| +32% | +$2.17K | ﹤0.01% | 5042 |
|
2021
Q1 | $7K | Sell |
402
-1,321
| -77% | -$23K | ﹤0.01% | 5163 |
|
2020
Q4 | $32K | Buy |
1,723
+813
| +89% | +$15.1K | ﹤0.01% | 4366 |
|
2020
Q3 | $20K | Sell |
910
-460
| -34% | -$10.1K | ﹤0.01% | 3975 |
|
2020
Q2 | $40K | Sell |
1,370
-278
| -17% | -$8.12K | ﹤0.01% | 3883 |
|
2020
Q1 | $58K | Buy |
1,648
+519
| +46% | +$18.3K | ﹤0.01% | 3686 |
|
2019
Q4 | $28K | Buy |
+1,129
| New | +$28K | ﹤0.01% | 4344 |
|